Robin Gibbs
Known title: CEO, SiriusPoint InternationalCIK: 0001968249
Associated companies
Transaction History
| SPNT | ▼ Sell | Tax Withholding | 2,174 | $51K | 4/30/2026 | View on chart |
| SPNT | ▲ Buy | Grant | 10,766 | $0 | 4/28/2026 | View on chart |
| SPNT | ▼ Sell | Tax Withholding | 72,375 | $1.6M | 4/14/2026 | View on chart |
| SPNT | ▼ Sell | Tax Withholding | 4,021 | $91K | 4/14/2026 | View on chart |
| SPNT | ▼ Sell | Tax Withholding | 2,719 | $62K | 4/14/2026 | View on chart |
| SPNT | ▲ Buy | Grant | 153,988 | $0 | 2/26/2026 | View on chart |
| SPNT | ▲ Buy | Grant | 13,875 | $0 | 4/25/2025 | View on chart |
| SPNT | ▼ Sell | Tax Withholding | 4,021 | $0 | 4/14/2025 | View on chart |
| SPNT | ▼ Sell | Tax Withholding | 2,718 | $0 | 4/14/2025 | View on chart |
| SPNT | ▲ Buy | Grant | 17,347 | $0 | 4/29/2024 | View on chart |
| SPNT | ▼ Sell | Tax Withholding | 4,021 | $0 | 4/14/2024 | View on chart |
| SPNT | ▼ Sell | Tax Withholding | 30,570 | $337K | 12/12/2023 | View on chart |
| SPNT | ▲ Buy | Grant | 25,665 | $0 | 4/18/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
SiriusPoint (SPNT) Valuation Questioned After Recent Price Rise
Recent market discussion has focused on whether SiriusPoint remains undervalued following a recent increase in its share price. The company currently trades with a low trailing P/E ratio of 5.7, which is significantly below the average analyst target of $28.75. This valuation gap has prompted investors to reassess the stock's position within its 52-week range of $17.39 to $26.50.
SiriusPoint (SPNT) Valuation Questioned After Recent Price Rise. Recent market discussion has focused on whether SiriusPoint remains undervalued following a recent increase in its share price. The company currently trades with a low trailing P/E ratio of 5.7, which is significantly below the average analyst target of $28.75. This valuation gap has prompted investors to reassess the stock's position within its 52-week range of $17.39 to $26.50.